Last reviewed · How we verify
Hemorrhaging in Hemophilia
Approved treatments
- Cyklokapron · Exela Pharma
Tranexamic acid works by binding to plasminogen and preventing its conversion to plasmin, thereby inhibiting fibrinolysis. - Amchafibrin · Fundación Pública Andaluza Progreso y Salud
- transamin · Erzincan Military Hospital
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Hemorrhaging in Hemophilia patent landscape — cliff calendar, originator estates, attackable patents
- Hemorrhaging in Hemophilia treatment landscape brief
- Hemorrhaging in Hemophilia treatment updates RSS
Frequently asked questions about Hemorrhaging in Hemophilia
What drugs treat Hemorrhaging in Hemophilia?
Tracked treatments include Cyklokapron, Amchafibrin, transamin.
What is the treatment for Hemorrhaging in Hemophilia?
Standard treatment for Hemorrhaging in Hemophilia includes Cyklokapron, Amchafibrin, transamin. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Hemorrhaging in Hemophilia patent cliff · Hemorrhaging in Hemophilia CI report
- Treatment: Cyklokapron · Exela Pharma
- Treatment: Amchafibrin · Fundación Pública Andaluza Progreso y Salud
- Treatment: transamin · Erzincan Military Hospital
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing